The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cancer risk in systemic lupus: An updated international multi-centre cohort study
Open accessAbstract
OBJECTIVE To update estimates of cancer risk in SLE relative to the general population. METHODS A multisite international SLE cohort was linked with regional tumor registries. Standardized incidence ratios (SIRs) were calculated as the ratio of observed to expected cancers. RESULTS Across 30 centres, 16,409 patients were observed for 121,283 (average 7.4) person-years. In total, 644 cancers occurred. Some cancers, notably hematologic malignancies, were substantially increased (SIR 3.02, 95% confidence interval, CI, 2.48, 3.63), particularly non-Hodgkin’s lymphoma, NHL (SIR 4.39, 95% CI 3.46, 5.49) and leukemia. In addition, increased risks of cancer of the vulva (SIR 3.78, 95% CI 1.52, 7.78), lung (SIR 1.30, 95% CI 1.04, 1.60), thyroid (SIR 1.76, 95% CI 1.13, 2.61) and possibly liver (SIR 1.87, 95% CI 0.97, 3.27) were suggested. However, a decreased risk was estimated for breast (SIR 0.73, 95% CI 0.61–0.88), endometrial (SIR 0.44, 95% CI 0.23–0.77), and possibly ovarian cancers (0.64, 95% CI 0.34–1.10). The variability of comparative rates across different cancers meant that only a small increased risk was estimated across all cancers (SIR 1.14, 95% CI 1.05, 1.23). CONCLUSION These data estimate only a small increased risk in SLE (versus the general population) for cancer over-all. However, there is clearly an increased risk of NHL, and cancers of the vulva, lung, thyroid, and possibly liver. It remains unclear to what extent the association with NHL is mediated by innate versus exogenous factors. Similarly, the etiology of the decreased breast, endometrial, and possibly ovarian cancer risk is uncertain, though investigations are ongoing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Self-citationIncreased Risk of Lymphoma in Sicca Syndrome
KASSAN, S. S., THOMAS, T. L., MOUTSOPOULOS, H. M., HOOVER, R., KIMBERLY, R. P., BUDMAN, D. R., COSTA, J., DECKER, J. L., & CHUSED, T. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-6-888 · Cited by 1,012
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
Smitten, A. L., Simon, T. A., Hochberg, M. C., & Suissa, S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2404 · Cited by 474
An international cohort study of cancer in systemic lupus erythematosus
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21029 · Cited by 353
Self-citationMok, C. C., Ho, L. Y., Fong, L. S., & To, C. H. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201393 · Cited by 213
Chao, C., Klein, N. P., Velicer, C. M., Sy, L. S., Slezak, J. M., Takhar, H., Ackerson, B., Cheetham, T. C., Hansen, J., Deosaransingh, K., et al. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02467.x · Cited by 199
Self-citationIncreased risk of cancer in patients with systemic lupus erythematosus.
Pettersson, T., Pukkala, E., Teppo, L., & Friman, C. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.4.437 · Cited by 194
Incidence of Second Cancers in Patients Treated for Hodgkin's Disease
Boivin, J.-F., Hutchison, G. B., Zauber, A. G., Bernstein, L., Davis, F. G., Michel, R. P., Zanke, B., Tan, C. T. C., Fuller, L. M., Mauch, P., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.732 · Cited by 184
Self-citationMalignancy in systemic lupus erythematosus
Abu‐Shakra, M., Gladman, D. D., & Urowitz, M. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390625 · Cited by 179
Self-citationAntimalarials may influence the risk of malignancy in systemic lupus erythematosus
Ruiz‐Irastorza, G., Ugarte, A., Egurbide, M.-V., Garmendia, M., Pijoan, J. I., Martínez-Berriotxoa, A., & Aguirre, C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.067777 · Cited by 128
Self-citationPrevalence of thyroid dysfunctions in systemic lupus erythematosus
Antonelli, A., Fallahi, P., Mosca, M., Ferrari, S. M., Ruffilli, I., Corti, A., Panicucci, E., Neri, R., & Bombardieri, S. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.010 · Cited by 109
Rahim-Bata, R., & Strobl, J. S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832f4e50 · Cited by 105
Effects of physical activity on cancer prevention
Na, H., & Oliynyk, S. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06105.x · Cited by 103
Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis
Bernatsky, S., Ramsey‐Goldman, R., Foulkes, W. D., Gordon, C., & Clarke, A. E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.115 · Cited by 95
Self-citationEpidemiological and Clinical Aspects of Nonsteroidal Anti-inflammatory Drugs and Cancer Risks
Moran, E. M. (2002) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v21.i2.130 · Cited by 92
Aspirin and lung cancer in women
Akhmedkhanov, A., Toniolo, P. G., Zeleniuch‐Jacquotte, A., Koenig, K. L., & Shore, R. E. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600370 · Cited by 83
Autophagy-induced tumor dormancy in ovarian cancer
Amaravadi, R. K. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37667 · Cited by 70
Molecular pathogenesis of follicular lymphoma
Ott, G., & Rosenwald, A. (2008) · Haematologica · doi:10.3324/haematol.2008.001495 · Cited by 61
Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Antonelli, A., Mosca, M., Fallahi, P., Neri, R., Ferrari, S. M., d’Ascanio, A., Ghiri, E., Carli, L., Miccoli, P., & Bombardieri, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0677 · Cited by 57
Autoimmune Thyroid Disease: A Risk Factor for Thyroid Cancer
Azizi, G., & Malchoff, C. D. (2010) · Endocrine Practice · doi:10.4158/ep10123.or · Cited by 55
Lung cancer in systemic lupus erythematosus
Bin, J., Bernatsky, S., Gordon, C., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.01.007 · Cited by 53
Self-citationBernatsky, S., Boivin, J., Joseph, L., Pierre, Y. S., Moore, A., Rajan, R., & Clarke, A. E. (2002) · PubMed · Cited by 48
Self-citation
Cited by
Andreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945
The global burden of SLE: prevalence, health disparities and socioeconomic impact
Carter, E. E., Barr, S. G., & Clarke, A. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.137 · Cited by 497
Self-citationGordon, C., Amissah-Arthur, M.-B., Gayed, M., Brown, S., Bruce, I. N., D’Cruz, D., Empson, B., Griffiths, B., Jayne, D., Khamashta, M., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/kex286 · Cited by 365
Self-citationYurkovich, M., Vostretsova, K., Chen, W., & Aviña‐Zubieta, J. A. (2014) · Arthritis Care & Research · doi:10.1002/acr.22173 · Cited by 356
Rekvig, O. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01104 · Cited by 65
Metadata
- Authors
- Bernatsky, S., Ramsey-Goldman, R., Labrecque, J., Joseph, L., Boivin, J.-F., Petri, M., Zoma, A., Manzi, S., Urowitz, M. B., Gladman, D., Fortin, P. R., Ginzler, E., Yelin, E., Bae, S.-C., Wallace, D. J., Edworthy, S., Jacobsen, S., Gordon, C., Dooley, M. A., Peschken, C. A., Hanly, J. G., Alarcón, G. S., Nived, O., Ruiz-Irastorza, G., Isenberg, D., Rahman, A., Witte, T., Aranow, C., Kamen, D. L., Steinsson, K., Askanase, A., Barr, S., Criswell, L. A., Sturfelt, G., Patel, N. M., Senécal, J.-L., Zummer, M., Pope, J. E., Ensworth, S., El-Gabalawy, H., McCarthy, T., Dreyer, L., Sibley, J., St. Pierre, Y., & Clarke, A. E.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 42
- Pages
- 130-135
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W1981117687
- Cited by
- 299
- References
- 23
- FWCI
- 18.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.